SCOPUS 정보 검색 플랫폼

Volumn 5, Issue 2, 1999, Pages 75-82

Stability of topotecan infusion solutions in polyvinylchloride bags and elastomeric portable infusion devices

Author keywords

Elastomeric infusion device; Infusion solution; Polyvinylchloride bag; Stability; Topotecan

Indexed keywords

EID: 33845514187 PISSN: 10781552 EISSN: 1477092X Source Type: Journal
DOI: 10.1177/107815529900500203 Document Type: Article

Times cited : (10)

References (15)

1
- 0028878831
- Topoisomerase inhibitors: A review of their therapeutic potential in cancer
- Sinha BK. Topoisomerase inhibitors: A review of their therapeutic potential in cancer. Drugs. 1995;49:11-19.
- (1995) Drugs , vol.49 , pp. 11-19
- Sinha, B.K.¹

2
- 0027096415
- A kinetic and mechanistic study of the hydrolysis of camptothecin and some analogues
- Fassberg J, Stella VJ. A kinetic and mechanistic study of the hydrolysis of camptothecin and some analogues. J Pharm Sci.1992;81:676-684.
- (1992) J Pharm Sci , vol.81 , pp. 676-684
- Fassberg, J.¹ Stella, V.J.²

3
- 0025663422
- Equilibrium kinetics of the new experimental antitumour compound SK&F 104864-A in aqueous solution
- Underberg WJM, Goossen RMJ, Smith BR, Beijnen JH. Equilibrium kinetics of the new experimental antitumour compound SK&F 104864-A in aqueous solution. J Pharm Biomed Anal. 1990;8:681-683.
- (1990) J Pharm Biomed Anal , vol.8 , pp. 681-683
- Underberg, W.J.M.¹ Goossen, R.M.J.² Smith, B.R.³ Beijnen, J.H.⁴

4
- 0026537874
- Phase I and pharmacologic study of topotecan: A novel topoisomerase I inhibitor
- Rowinsky EK, Grochow LB, Hendriks CB, et al. Phase I and pharmacologic study of topotecan: A novel topoisomerase I inhibitor. J Clin Oncol. 1992;10:647-656.
- (1992) J Clin Oncol , vol.10 , pp. 647-656
- Rowinsky, E.K.¹ Grochow, L.B.² Hendriks, C.B.³

5
- 0029947777
- Clinical pharmacokinetics of topotecan
- Herben VMM, Ten Bokkel Huinink WW, Beijnen JH. Clinical pharmacokinetics of topotecan. Clin Pharmacokinet. 1996;31: 85-102.
- (1996) Clin Pharmacokinet , vol.31 , pp. 85-102
- Herben, V.M.M.¹ Ten Bokkel Huinink, W.W.² Beijnen, J.H.³

6
- 0027935576
- Phase I and pharmacokinetic studies of topotecan administered as a 72- or 120-h continuous infusion
- Burris HA III, Awada A, Kuhn JG, et al. Phase I and pharmacokinetic studies of topotecan administered as a 72- or 120-h continuous infusion. Anticancer Drugs. 1994;5:394-402.
- (1994) Anticancer Drugs , vol.5 , pp. 394-402
- Burris III, H.A.¹ Awada, A.² Kuhn, J.G.³

7
- 0026646768
- Pharmacokinetics and pharmacodynamics of topotecan in patients with advanced cancer
- Grochow LB, Rowinsky EK, Johnson R, et al. Pharmacokinetics and pharmacodynamics of topotecan in patients with advanced cancer. Drug Metab Dispos. 1992;20:706-713.
- (1992) Drug Metab Dispos , vol.20 , pp. 706-713
- Grochow, L.B.¹ Rowinsky, E.K.² Johnson, R.³

8
- 0029890912
- Pharmacokinetics and pharmacodynamics of topotecan given on a daily-times-five schedule in phase II clinical trials using a limited-sampling procedure
- Van Warmerdam LJC, Creemers GJ, Rodenbuis S, et al. Pharmacokinetics and pharmacodynamics of topotecan given on a daily-times-five schedule in phase II clinical trials using a limited-sampling procedure. Cancer Chemother Pharmacol. 1996;38: 254-260.
- (1996) Cancer Chemother Pharmacol , vol.38 , pp. 254-260
- Van Warmerdam, L.J.C.¹ Creemers, G.J.² Rodenbuis, S.³

9
- 79959679706
- Hycamtin®. Standard information für Krankenhausapotheker. München, Germany: SmithKline Beecham Pharma; February 1997
- Hycamtin®. Standard information für Krankenhausapotheker. München, Germany: SmithKline Beecham Pharma; February 1997.

10
- 0029876372
- Preformulation studies to aid in the development of a ready-to-use injectable solution of the antitumor agent, topotecan
- Kearney AS, Patel K, Palepu NR. Preformulation studies to aid in the development of a ready-to-use injectable solution of the antitumor agent, topotecan. Int J Pharm. 1995;127:229-237.
- (1995) Int J Pharm , vol.127 , pp. 229-237
- Kearney, A.S.¹ Patel, K.² Palepu, N.R.³

11
- 0030784563
- Stability and compatibility of topotecan hydrochloride for injection with common infusion solutions and containers
- Craig SB, Bhatt UH, Patel K. Stability and compatibility of topotecan hydrochloride for injection with common infusion solutions and containers. J Pharm Biomed Anal. 1997;16:199-205.
- (1997) J Pharm Biomed Anal , vol.16 , pp. 199-205
- Craig, S.B.¹ Bhatt, U.H.² Patel, K.³

12
- 0030787038
- Pharmazeutische Aspekte von Topotecan-Infusionen
- Krämer I, Thiesen J. Pharmazeutische Aspekte von Topotecan-Infusionen. Pharm TG. 1997;31:30-33.
- (1997) Pharm TG , vol.31 , pp. 30-33
- Krämer, I.¹ Thiesen, J.²

13
- 0029923846
- Stability of dextrose and sodium chloride in injectable solutions stored in an elastomeric infusion device
- Lima HA, Lennon J, Sesterhenn K, Spychala K. Stability of dextrose and sodium chloride in injectable solutions stored in an elastomeric infusion device. Am J Health Syst Pharm. 1996;53:794-795.
- (1996) Am J Health Syst Pharm , vol.53 , pp. 794-795
- Lima, H.A.¹ Lennon, J.² Sesterhenn, K.³ Spychala, K.⁴

14
- 0025202236
- Prediction of water vapor transport rates across polyvinylchloride packing systems using a novel radiotracer method
- Wood RW, Mulski MJ, Kuu WY. Prediction of water vapor transport rates across polyvinylchloride packing systems using a novel radiotracer method. J Parenter Sci Technol. 1990;44:278-281.
- (1990) J Parenter Sci Technol , vol.44 , pp. 278-281
- Wood, R.W.¹ Mulski, M.J.² Kuu, W.Y.³

15
- 0008356489
- Viability of microorganisms in novel antineoplastic and antiviral drug solutions
- Krämer I. Viability of microorganisms in novel antineoplastic and antiviral drug solutions. J Oncol Pharm Practice. 1998;4:32-37.
- (1998) J Oncol Pharm Practice , vol.4 , pp. 32-37
- Krämer, I.¹

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.